Clazosentan in aneurysmal subarachnoid hemorrhage: an updated systematic review and meta-analysis of efficacy and safety

Abstract Introduction Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening neurological condition associated with high morbidity and mortality. Delayed cerebral ischemia (DCI), largely driven by cerebral vasospasm, remains a major determinant of poor outcomes. Clazosentan, a selective end...

詳細記述

書誌詳細

主要な著者:	Abdulelah Mohammed Alsakti, Zahra Hassan Al Ghazwi, Abdulrahman Khalid AlOtaibi, Mohammed Abdullah Alharbi, Layan Ali Aldeaiji, Abdulaziz Bijad Binshmilan, Naif Mohammed M. Alanazi, Rehaf Essa Alsharif, Fahad Mohammed Aldehaim, Basil Anas Alhindi, Norah Abdullah Alodhaib, Aalaa Saleh, Abdullah Altamimi
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2026-06-01
シリーズ:	BMC Neurology
主題:	Aneurysmal subarachnoid hemorrhage Clazosentan Cerebral vasospasm Delayed cerebral ischemia Meta-analysis
オンライン･アクセス:	https://doi.org/10.1186/s12883-026-05016-y
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!